The dividend payment is scheduled for distribution on October 15, 2026. To qualify for the disbursement, investors must be listed as shareholders of record by the close of business on October 1, 2026.
Cardinal Health maintains a broad portfolio spanning pharmaceutical distribution, medical product manufacturing, and specialized nuclear pharmacy operations. The company provides a range of data-driven performance solutions across its global network, supporting both direct-to-patient services and large-scale laboratory supply chains.





Comments (0)
No comments yet. Be the first!